SPY316.18+2.40 0.76%
DIA260.72+1.68 0.65%
IXIC10,492.50+148.61 1.44%

Milestone Pharmaceuticals Q3 EPS $(0.52) Up From $(20.16) YoY

Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.52) per share. This is a 97.42 percent increase over losses of $(20.16) per share from the same period last year.

Benzinga · -

Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.52) per share. This is a 97.42 percent increase over losses of $(20.16) per share from the same period last year.